(Q36165987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Steatosis: co-factor in other liver diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Andrew D. Clouston

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Julie R Jonsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

5-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15962320%20AND%20SRC:MED&resulttype=core&format=json

Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease

13 January 2020

cites work

1 reference

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease

21 January 2018

1 reference

The development and compensation of biliary cirrhosis in interleukin-6-deficient mice

21 January 2018

1 reference

Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.

21 January 2018

1 reference

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

7 January 2021

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

7 January 2021

Hepatic steatosis: innocent bystander or guilty party?

1 reference

7 January 2021

Interaction of non-alcoholic fatty liver disease with other liver diseases.

1 reference

7 January 2021

The pathology of hepatitis C

1 reference

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

1 reference

7 January 2021

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

7 January 2021

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

7 January 2021

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

7 January 2021

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

7 January 2021

Fibrogenic impact of high serum glucose in chronic hepatitis C.

1 reference

7 January 2021

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

7 January 2021

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

7 January 2021

Steatosis and fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

7 January 2021

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

1 reference

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

7 January 2021

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

7 January 2021

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

7 January 2021

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

1 reference

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

7 January 2021

DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study

1 reference

7 January 2021

The mechanisms underlying hepatitis C virus genotype 3-mediated liver damage

1 reference

7 January 2021

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

1 reference

7 January 2021

The keratin cytoskeleton in liver diseases

1 reference

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

7 January 2021

Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury

1 reference

7 January 2021

Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury

1 reference

7 January 2021

Worsening of steatosis and fibrosis progression

1 reference

7 January 2021

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

7 January 2021

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

7 January 2021

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

7 January 2021

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

1 reference

7 January 2021

Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

7 January 2021

Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration

1 reference

7 January 2021

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

1 reference

7 January 2021

Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease

1 reference

7 January 2021

Heterogeneity and plasticity of hepatocyte lineage cells

1 reference

7 January 2021

Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis

1 reference

7 January 2021

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

7 January 2021

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

1 reference

7 January 2021

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

1 reference

7 January 2021

The spectrum of liver disease in the general population: lesson from the Dionysos study.

1 reference

7 January 2021

Excess weight risk factor for alcoholic liver disease

1 reference

7 January 2021

Risk factors of fibrosis in alcohol-induced liver disease

1 reference

7 January 2021

Obesity and alcoholic liver disease

1 reference

7 January 2021

Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis

1 reference

7 January 2021

Dietary fat and alcoholic liver disease

1 reference

7 January 2021

Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

1 reference

7 January 2021

Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients

1 reference

7 January 2021

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

1 reference

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

7 January 2021

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

7 January 2021

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice

1 reference

7 January 2021

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

7 January 2021

Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease

1 reference

7 January 2021

The role of progenitor cells in repair of liver injury and in liver transplantation

1 reference

7 January 2021

Hepatic 'stem cell' malignancies in adults: four cases.

1 reference

7 January 2021

Animal models of human disease in drug safety assessment

1 reference

7 January 2021

Drugs and the liver updated, 2002

1 reference

7 January 2021

Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury

1 reference

7 January 2021

Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease

1 reference

7 January 2021

Iron as a co-morbid factor in nonhemochromatotic liver disease

1 reference

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

1 reference

7 January 2021

Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes

1 reference

7 January 2021

Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome

1 reference

7 January 2021

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

7 January 2021

Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance

1 reference

7 January 2021

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

1 reference

7 January 2021

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

7 January 2021

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

1 reference

7 January 2021

Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.

1 reference

7 January 2021

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

1 reference

7 January 2021